The 2022 ACR vaccination guideline: a call-to-action

Among the limited quality and quantity of evidence on vaccination use in individuals with rheumatic and musculoskeletal diseases, a new guideline, developed with a rigorous methodology, provides useful support to clinicians and patients in making health-related decisions. Most recommendations are conditional, serving as a call to action for further research.

Automated summary

Regarding vaccination in individuals with rheumatic and musculoskeletal diseases, the limited evidence available is supplemented by a new guideline that follows a rigorous methodology, offering valuable guidance to healthcare professionals and patients. The majority of recommendations are conditional, emphasizing the need for more research.